ChoA Pharmaceutical Co.Ltd (034940) - Net Assets

Latest as of March 2026: ₩21.62 Billion KRW ≈ $14.65 Million USD

Based on the latest financial reports, ChoA Pharmaceutical Co.Ltd (034940) has net assets worth ₩21.62 Billion KRW (≈ $14.65 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩63.04 Billion ≈ $42.72 Million USD) and total liabilities (₩41.42 Billion ≈ $28.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 034940 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩21.62 Billion
% of Total Assets	34.29%
Annual Growth Rate	-1.18%
5-Year Change	-56.4%
10-Year Change	-54.5%
Growth Volatility	32.6

ChoA Pharmaceutical Co.Ltd - Net Assets Trend (2001–2025)

This chart illustrates how ChoA Pharmaceutical Co.Ltd's net assets have evolved over time, based on quarterly financial data. See ChoA Pharmaceutical Co.Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for ChoA Pharmaceutical Co.Ltd (2001–2025)

The table below shows the annual net assets of ChoA Pharmaceutical Co.Ltd from 2001 to 2025. For live valuation and market cap data, see 034940 company net worth.

Year	Net Assets	Change
2025-12-31	₩21.77 Billion ≈ $14.75 Million	-30.63%
2024-12-31	₩31.38 Billion ≈ $21.26 Million	-19.05%
2023-12-31	₩38.76 Billion ≈ $26.27 Million	-26.66%
2022-12-31	₩52.84 Billion ≈ $35.81 Million	+5.86%
2021-12-31	₩49.92 Billion ≈ $33.83 Million	-14.38%
2020-12-31	₩58.30 Billion ≈ $39.51 Million	+9.89%
2019-12-31	₩53.06 Billion ≈ $35.96 Million	-1.68%
2018-12-31	₩53.96 Billion ≈ $36.57 Million	-0.39%
2017-12-31	₩54.18 Billion ≈ $36.71 Million	+13.25%
2016-12-31	₩47.84 Billion ≈ $32.42 Million	+1.45%
2015-12-31	₩47.15 Billion ≈ $31.96 Million	+2.31%
2014-12-31	₩46.09 Billion ≈ $31.23 Million	-8.96%
2013-12-31	₩50.63 Billion ≈ $34.31 Million	+56.54%
2005-12-31	₩32.34 Billion ≈ $21.92 Million	+102.83%
2004-12-31	₩15.94 Billion ≈ $10.81 Million	+7.70%
2003-12-31	₩14.80 Billion ≈ $10.03 Million	-36.95%
2002-12-31	₩23.48 Billion ≈ $15.91 Million	-18.96%
2001-12-31	₩28.98 Billion ≈ $19.64 Million	--

Equity Component Analysis

This analysis shows how different components contribute to ChoA Pharmaceutical Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5417975425000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	₩79.19 Billion	316.67%
Total Equity	₩25.01 Billion	100.00%

ChoA Pharmaceutical Co.Ltd Competitors by Market Cap

The table below lists competitors of ChoA Pharmaceutical Co.Ltd ranked by their market capitalization.

Company	Market Cap
BBGI SICAV SA LSE:BBGI	$12.33 Million
Sarytogan Graphite Ltd AU:SGA	$12.34 Million
Glimpse Group Inc NASDAQ:VRAR	$12.35 Million
Nidaros Sparebank OL:NISB	$12.35 Million
Peak Processing Limited AU:PKP	$12.32 Million
Petrolympic Ltd V:PCQ	$12.32 Million
Regenbogen AG F:RGB	$12.30 Million
Photomyne Ltd TA:PHTM	$12.29 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ChoA Pharmaceutical Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 31,375,771,030 to 25,005,304,950, a change of -6,370,466,080 (-20.3%).
Net loss of 6,805,775,550 reduced equity.
Other factors increased equity by 435,309,470.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-6.81 Billion	-27.22%
Other Changes	₩435.31 Million	+1.74%
Total Change	₩-	-20.30%

Book Value vs Market Value Analysis

This analysis compares ChoA Pharmaceutical Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.73x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.35x to 0.73x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩1689.83	₩587.00	x
2017-12-31	₩1913.65	₩587.00	x
2018-12-31	₩1906.19	₩587.00	x
2019-12-31	₩1874.10	₩587.00	x
2020-12-31	₩1881.94	₩587.00	x
2021-12-31	₩1611.38	₩587.00	x
2022-12-31	₩1705.75	₩587.00	x
2023-12-31	₩1323.22	₩587.00	x
2024-12-31	₩1012.78	₩587.00	x
2025-12-31	₩807.15	₩587.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently ChoA Pharmaceutical Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -27.22%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -11.47%
• Asset Turnover: 0.92x
• Equity Multiplier: 2.59x
Recent ROE (-27.22%) is below the historical average (-6.53%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	9.60%	7.58%	0.53x	2.37x	₩-64.21 Million
2013	3.52%	4.11%	0.62x	1.38x	₩-3.31 Billion
2014	-8.72%	-9.46%	0.58x	1.59x	₩-8.75 Billion
2015	2.11%	2.02%	0.67x	1.55x	₩-3.77 Billion
2016	0.34%	0.29%	0.74x	1.57x	₩-4.62 Billion
2017	3.00%	2.76%	0.70x	1.54x	₩-3.79 Billion
2018	1.19%	1.02%	0.75x	1.56x	₩-4.76 Billion
2019	-1.71%	-1.34%	0.78x	1.63x	₩-6.21 Billion
2020	-2.26%	-2.02%	0.79x	1.41x	₩-7.15 Billion
2021	-16.11%	-13.97%	0.71x	1.61x	₩-13.04 Billion
2022	1.06%	0.81%	0.80x	1.62x	₩-4.72 Billion
2023	-25.65%	-16.70%	0.85x	1.81x	₩-14.61 Billion
2024	-30.61%	-15.32%	0.88x	2.27x	₩-12.74 Billion
2025	-27.22%	-11.47%	0.92x	2.59x	₩-9.31 Billion

Industry Comparison

This section compares ChoA Pharmaceutical Co.Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $329,362,045,253
Average return on equity (ROE) among peers: 3.99%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
ChoA Pharmaceutical Co.Ltd (034940)	₩21.62 Billion	9.60%	1.92x	$12.32 Million
Dongwha Pharm.Co.Ltd (000020)	$297.40 Billion	3.39%	0.25x	$97.49 Million
Yuhan Corp. (000100)	$519.03 Billion	9.81%	0.47x	$3.90 Billion
Yuhan Corp Preferred (000105)	$1.65 Trillion	3.48%	0.32x	$51.83 Million
Yuyu Pharma (000220)	$128.69 Billion	-1.72%	0.50x	$43.48 Million
Yuyu Pharma Inc (000225)	$120.36 Billion	-5.97%	0.65x	$14.47 Million
Yuyu Pharma Inc (000227)	$86.87 Billion	4.63%	0.56x	$42.09 Million
Ildong Holdings Co Ltd (000230)	$55.81 Billion	8.24%	2.38x	$53.57 Million
Samil Pharm (000520)	$54.41 Billion	1.08%	0.83x	$101.43 Million
Donga Socio Holdings (000640)	$266.72 Billion	7.48%	1.59x	$367.37 Million
Jw Pharmac (001060)	$112.60 Billion	9.51%	2.66x	$416.42 Million

About ChoA Pharmaceutical Co.Ltd

KQ:034940 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$12.32 Million

₩18.19 Billion KRW

Market Cap Rank

#26523 Global

#1946 in Korea

Share Price

₩587.00

Change (1 day)

-6.83%

52-Week Range

₩587.00 - ₩1269.00

All Time High

₩8100.00